Infections of the spine: Current concepts and a literature review
Keywords:
Spine Infections, Spondylitis, Spondylodiscitis, Pathogenesis, Clinical Presentation, Back pain
Abstract
Infections of the spine comprise a wide spectrum of different clinical manifestations depending on the exact anatomical structure involved. Spinal infections pose an essential health problem, the treatment of which requires a multidisciplinary approach. Diagnosis is based on clinical symptoms, radiologic evidence, laboratory tests and biopsy. The most common pathogens are bacteria; most of which spread hematogenously. Current treatment involves a combination of antibiotic agents. Sometimes, surgery is required to eradicate the infection or to treat its complications. In all cases, thorough and repetitive clinical examination and laboratory tests are of paramount importance for optimal outcomes.
Downloads
Download data is not yet available.
References
[1] D. M. Kaufman, J. G. Kaplan, and N. Litman, “Infectious agents in spinal epidural abscesses,” Neurology, vol. 30, no. 8, pp. 844–850, Aug. 1980, doi: 10.1212/wnl.30.8.844.
[2] R. R. Calderone and J. M. Larsen, “Overview and classification of spinal infections,” Orthop. Clin. North Am., vol. 27, no. 1, pp. 1–8, Jan. 1996.
[3] L. Grammatico et al., “Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002–2003,” Epidemiol. Infect., vol. 136, no. 5, pp. 653–660, May 2008, doi: 10.1017/S0950268807008850.
[4] K. Y. Lee, “Comparison of Pyogenic Spondylitis and Tuberculous Spondylitis,” Asian Spine J., vol. 8, no. 2, p. 216, 2014, doi: 10.4184/asj.2014.8.2.216.
[5] A. G. Jensen, F. Espersen, P. Skinhøj, V. T. Rosdahl, and N. Frimodt-Møller, “Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980–1990,” J. Infect., vol. 34, no. 2, pp. 113–118, Mar. 1997, doi: 10.1016/S0163-4453(97)92395-1.
[6] J. Solera, E. Lozano, E. Martinez-Alfaro, A. Espinosa, M. L. Castillejos, and L. Abad, “Brucellar Spondylitis: Review of 35 Cases and Literature Survey,” Clin. Infect. Dis., vol. 29, no. 6, pp. 1440–1449, Dec. 1999, doi: 10.1086/313524.
[7] J. L. Cebrián Parra, A. Saez-Arenillas Martín, A. L. Urda Martínez-Aedo, I. Soler Ivañez, E. Agreda, and L. Lopez-Duran Stern, “Management of infectious discitis. Outcome in one hundred and eight patients in a University Hospital,” Int. Orthop., vol. 36, no. 2, pp. 239–244, Feb. 2012, doi: 10.1007/s00264-011-1445-x.
[8] E. T. Tali, “Spinal infections,” Eur. J. Radiol., vol. 50, no. 2, pp. 120–133, May 2004, doi: 10.1016/j.ejrad.2003.10.022.
[9] A. S. Smith and S. I. Blaser, “Infectious and inflammatory processes of the spine,” Radiol. Clin. North Am., vol. 29, no. 4, pp. 809–827, Jul. 1991.
[10] M. J. Patzakis, S. Rao, J. Wilkins, T. M. Moore, and P. J. Harvey, “Analysis of 61 cases of vertebral osteomyelitis,” Clin. Orthop., no. 264, pp. 178–183, Mar. 1991.
[11] J. D. Colmenero et al., “Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases,” Ann. Rheum. Dis., vol. 56, no. 12, pp. 709–715, Dec. 1997, doi: 10.1136/ard.56.12.709.
[12] J. F. Griffith, S. M. Kumta, P. C. Leung, J. C. Y. Cheng, L. T. C. Chow, and C. Metreweli, “Imaging of musculoskeletal tuberculosis: a new look at an old disease,” Clin. Orthop., no. 398, pp. 32–39, May 2002, doi: 10.1097/00003086-200205000-00006.
[13] D. W. Park et al., “Outcome and management of spinal tuberculosis according to the severity of disease: a retrospective study of 137 adult patients at Korean teaching hospitals,” Spine, vol. 32, no. 4, pp. E130-135, Feb. 2007, doi: 10.1097/01.brs.0000255216.54085.21.
[14] D. L. Larson, K. A. Hudak, W. P. Waring, M. R. Orr, and K. Simonelic, “Protocol management of late-stage pressure ulcers: a 5-year retrospective study of 101 consecutive patients with 179 ulcers,” Plast. Reconstr. Surg., vol. 129, no. 4, pp. 897–904, Apr. 2012, doi: 10.1097/PRS.0b013e3182442197.
[15] M. A. Ameer, T. L. Knorr, and F. B. Mesfin, “Spinal Epidural Abscess,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2020.
[16] C. Michel-Batôt et al., “A particular form of septic arthritis: septic arthritis of facet joint,” Joint Bone Spine, vol. 75, no. 1, pp. 78–83, Jan. 2008, doi: 10.1016/j.jbspin.2007.02.006.
[17] V. Dufour et al., “Comparative study of postoperative and spontaneous pyogenic spondylodiscitis,” Semin. Arthritis Rheum., vol. 34, no. 5, pp. 766–771, Apr. 2005, doi: 10.1016/j.semarthrit.2004.08.004.
[18] M. A. Weinstein and F. J. Eismont, “Infections of the spine in patients with human immunodeficiency virus,” J. Bone Joint Surg. Am., vol. 87, no. 3, pp. 604–609, Mar. 2005, doi: 10.2106/JBJS.C.01062.
[19] A. Di Martino, R. Papalia, E. Albo, L. Diaz, L. Denaro, and V. Denaro, “Infection after spinal surgery and procedures,” Eur. Rev. Med. Pharmacol. Sci., vol. 23, no. 2 Suppl, pp. 173–178, Apr. 2019, doi: 10.26355/eurrev_201904_17487.
[20] N. A. S. Sai Kiran, S. Vaishya, S. S. Kale, B. S. Sharma, and A. K. Mahapatra, “Surgical results in patients with tuberculosis of the spine and severe lower-extremity motor deficits: a retrospective study of 48 patients,” J. Neurosurg. Spine, vol. 6, no. 4, pp. 320–326, Apr. 2007, doi: 10.3171/spi.2007.6.4.6.
[21] A. S. Baker, R. G. Ojemann, M. N. Swartz, and E. P. Richardson, “Spinal epidural abscess,” N. Engl. J. Med., vol. 293, no. 10, pp. 463–468, Sep. 1975, doi: 10.1056/NEJM197509042931001.
[22] A. M. Wiley and J. Trueta, “The vascular anatomy of the spine and its relationship to pyogenic vertebral osteomyelitis,” J. Bone Joint Surg. Br., vol. 41-B, pp. 796–809, Nov. 1959, doi: 10.1302/0301-620X.41B4.796.
[23] E. F. Berbari et al., “2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 61, no. 6, pp. e26-46, Sep. 2015, doi: 10.1093/cid/civ482.
[24] A. Rivas-Garcia, S. Sarria-Estrada, C. Torrents-Odin, L. Casas-Gomila, and E. Franquet, “Imaging findings of Pott’s disease,” Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc., vol. 22 Suppl 4, pp. 567–578, Jun. 2013, doi: 10.1007/s00586-012-2333-9.
[25] M. N. Gamaletsou et al., “Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome,” J. Infect., vol. 68, no. 5, pp. 478–493, May 2014, doi: 10.1016/j.jinf.2013.12.008.
[26] P. Kapeller et al., “Pyogenic infectious spondylitis: clinical, laboratory and MRI features,” Eur. Neurol., vol. 38, no. 2, pp. 94–98, 1997, doi: 10.1159/000113167.
[27] A. F. Mavrogenis, G. K. Triantafyllopoulos, K. Kokkinis, A. Stefos, N. V. Sipsas, and S. G. Pneumaticos, “Continuous L3 spondylitis caused by an infected endovascular aortic graft,” Surg. Infect., vol. 15, no. 6, pp. 861–862, Dec. 2014, doi: 10.1089/sur.2013.219.
[28] O. V. Batson, “The vertebral system of veins as a means for cancer dissemination,” Prog. Clin. Cancer, vol. 3, pp. 1–18, 1967.
[29] W.-C. Chang, H.-K. Tsou, T.-H. Kao, M.-Y. Yang, and C.-C. Shen, “Successful treatment of extended epidural abscess and long segment osteomyelitis: a case report and review of the literature,” Surg. Neurol., vol. 69, no. 2, pp. 117–120; discussion 120, Feb. 2008, doi: 10.1016/j.surneu.2006.12.047.
[30] F. L. Sapico and J. Z. Montgomerie, “Pyogenic vertebral osteomyelitis: report of nine cases and review of the literature,” Rev. Infect. Dis., vol. 1, no. 5, pp. 754–776, Oct. 1979, doi: 10.1093/clinids/1.5.754.
[31] M. Fantoni et al., “Epidemiological and clinical features of pyogenic spondylodiscitis,” Eur. Rev. Med. Pharmacol. Sci., vol. 16 Suppl 2, pp. 2–7, Apr. 2012.
[32] J. S. Butler, M. J. Shelly, M. Timlin, W. G. Powderly, and J. M. O’Byrne, “Nontuberculous pyogenic spinal infection in adults: a 12-year experience from a tertiary referral center,” Spine, vol. 31, no. 23, pp. 2695–2700, Nov. 2006, doi: 10.1097/01.brs.0000244662.78725.37.
[33] C. E. C. Goertz et al., “Brucella sp. vertebral osteomyelitis with intercurrent fatal Staphylococcus aureus toxigenic enteritis in a bottlenose dolphin (Tursiops truncatus),” J. Vet. Diagn. Investig. Off. Publ. Am. Assoc. Vet. Lab. Diagn. Inc, vol. 23, no. 4, pp. 845–851, Jul. 2011, doi: 10.1177/1040638711407683.
[34] A. L. Gasbarrini et al., “Clinical features, diagnostic and therapeutic approaches to haematogenous vertebral osteomyelitis,” Eur. Rev. Med. Pharmacol. Sci., vol. 9, no. 1, pp. 53–66, Feb. 2005.
[35] W. T. Davis, M. D. April, S. Mehta, B. Long, and S. Shroyer, “High risk clinical characteristics for pyogenic spinal infection in acute neck or back pain: Prospective cohort study,” Am. J. Emerg. Med., vol. 38, no. 3, pp. 491–496, 2020, doi: 10.1016/j.ajem.2019.05.025.
[36] W. Y. Cheung and K. D. K. Luk, “Pyogenic spondylitis,” Int. Orthop., vol. 36, no. 2, pp. 397–404, Feb. 2012, doi: 10.1007/s00264-011-1384-6.
[37] A. F. Mavrogenis et al., “Spondylodiscitis revisited,” EFORT Open Rev., vol. 2, no. 11, pp. 447–461, Nov. 2017, doi: 10.1302/2058-5241.2.160062.
[38] T. Aagaard, C. Roed, C. Dragsted, and P. Skinhøj, “Microbiological and therapeutic challenges in infectious spondylodiscitis: a cohort study of 100 cases, 2006-2011,” Scand. J. Infect. Dis., vol. 45, no. 6, pp. 417–424, Jun. 2013, doi: 10.3109/00365548.2012.753160.
[39] S. Choi et al., “Diagnostic usefulness of the QuantiFERON-TB gold in-tube test (QFT-GIT) for tuberculous vertebral osteomyelitis,” Infect. Dis. Lond. Engl., vol. 50, no. 5, pp. 346–351, 2018, doi: 10.1080/23744235.2017.1410282.
[40] E. Mylona, M. Samarkos, E. Kakalou, P. Fanourgiakis, and A. Skoutelis, “Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics,” Semin. Arthritis Rheum., vol. 39, no. 1, pp. 10–17, Aug. 2009, doi: 10.1016/j.semarthrit.2008.03.002.
[41] S. Rajasekaran, “The problem of deformity in spinal tuberculosis,” Clin. Orthop., no. 398, pp. 85–92, May 2002, doi: 10.1097/00003086-200205000-00012.
[42] V. Jevtic, “Vertebral infection,” Eur. Radiol., vol. 14 Suppl 3, pp. E43-52, Mar. 2004, doi: 10.1007/s00330-003-2046-x.
[43] A. Dagirmanjian, J. Schils, and M. C. McHenry, “MR imaging of spinal infections,” Magn. Reson. Imaging Clin. N. Am., vol. 7, no. 3, pp. 525–538, Aug. 1999.
[44] F. Maiuri, G. Iaconetta, B. Gallicchio, A. Manto, and F. Briganti, “Spondylodiscitis. Clinical and magnetic resonance diagnosis,” Spine, vol. 22, no. 15, pp. 1741–1746, Aug. 1997, doi: 10.1097/00007632-199708010-00012.
[45] M. M. Thurnher and R. Bammer, “Diffusion-weighted magnetic resonance imaging of the spine and spinal cord,” Semin. Roentgenol., vol. 41, no. 4, pp. 294–311, Oct. 2006, doi: 10.1053/j.ro.2006.07.003.
[46] E. J. Carragee, “Pyogenic vertebral osteomyelitis,” J. Bone Joint Surg. Am., vol. 79, no. 6, pp. 874–880, Jun. 1997, doi: 10.2106/00004623-199706000-00011.
[47] E. Lazzeri et al., “Clinical feasibility of two-step streptavidin/111In-biotin scintigraphy in patients with suspected vertebral osteomyelitis,” Eur. J. Nucl. Med. Mol. Imaging, vol. 31, no. 11, pp. 1505–1511, Nov. 2004, doi: 10.1007/s00259-004-1581-2.
[48] A. Lupetti, M. M. Welling, U. Mazzi, P. H. Nibbering, and E. K. J. Pauwels, “Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections,” Eur. J. Nucl. Med. Mol. Imaging, vol. 29, no. 5, pp. 674–679, May 2002, doi: 10.1007/s00259-001-0760-7.
[49] A. S. Tamm and J. T. Abele, “Bone and Gallium Single-Photon Emission Computed Tomography-Computed Tomography is Equivalent to Magnetic Resonance Imaging in the Diagnosis of Infectious Spondylodiscitis: A Retrospective Study,” Can. Assoc. Radiol. J. J. Assoc. Can. Radiol., vol. 68, no. 1, pp. 41–46, Feb. 2017, doi: 10.1016/j.carj.2016.02.003.
[50] S. Gratz et al., “18F-FDG hybrid PET in patients with suspected spondylitis,” Eur. J. Nucl. Med. Mol. Imaging, vol. 29, no. 4, pp. 516–524, Apr. 2002, doi: 10.1007/s00259-001-0719-8.
[51] K. Strobel and K. D. M. Stumpe, “PET/CT in musculoskeletal infection,” Semin. Musculoskelet. Radiol., vol. 11, no. 4, pp. 353–364, Dec. 2007, doi: 10.1055/s-2008-1060337.
[52] S. C. Foreman et al., “MR and CT Imaging to Optimize CT-Guided Biopsies in Suspected Spondylodiscitis,” World Neurosurg., vol. 99, pp. 726-734.e7, Mar. 2017, doi: 10.1016/j.wneu.2016.11.017.
[53] F. S. Chew and M. J. Kline, “Diagnostic yield of CT-guided percutaneous aspiration procedures in suspected spontaneous infectious diskitis,” Radiology, vol. 218, no. 1, pp. 211–214, Jan. 2001, doi: 10.1148/radiology.218.1.r01ja06211.
[54] A. Olscamp, J. Rollins, S. S. Tao, and N. A. Ebraheim, “Complications of CT-guided biopsy of the spine and sacrum,” Orthopedics, vol. 20, no. 12, pp. 1149–1152, Dec. 1997.
[55] F. Lecouvet, L. Irenge, B. Vandercam, A. Nzeusseu, S. Hamels, and J.-L. Gala, “The etiologic diagnosis of infectious discitis is improved by amplification-based DNA analysis,” Arthritis Rheum., vol. 50, no. 9, pp. 2985–2994, Sep. 2004, doi: 10.1002/art.20462.
[56] G. Wang et al., “Diagnostic accuracy evaluation of the conventional and molecular tests for Spinal Tuberculosis in a cohort, head-to-head study,” Emerg. Microbes Infect., vol. 7, no. 1, p. 109, Jun. 2018, doi: 10.1038/s41426-018-0114-1.
[57] G. Gras et al., “Microbiological diagnosis of vertebral osteomyelitis: relevance of second percutaneous biopsy following initial negative biopsy and limited yield of post-biopsy blood cultures,” Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol., vol. 33, no. 3, pp. 371–375, Mar. 2014, doi: 10.1007/s10096-013-1965-y.
[58] K. Fuursted, M. Arpi, B. E. Lindblad, and L. N. Pedersen, “Broad-range PCR as a supplement to culture for detection of bacterial pathogens in patients with a clinically diagnosed spinal infection,” Scand. J. Infect. Dis., vol. 40, no. 10, pp. 772–777, 2008, doi: 10.1080/00365540802119994.
[59] A. Navarro-Martínez, E. Navarro, M. J. Castaño, and J. Solera, “Rapid diagnosis of human brucellosis by quantitative real-time PCR: a case report of brucellar spondylitis,” J. Clin. Microbiol., vol. 46, no. 1, pp. 385–387, Jan. 2008, doi: 10.1128/JCM.01303-07.
[60] E. M. de Lucas et al., “CT-guided fine-needle aspiration in vertebral osteomyelitis: true usefulness of a common practice,” Clin. Rheumatol., vol. 28, no. 3, pp. 315–320, Mar. 2009, doi: 10.1007/s10067-008-1051-5.
[61] J. Marschall, K. P. Bhavan, M. A. Olsen, V. J. Fraser, N. M. Wright, and D. K. Warren, “The impact of prebiopsy antibiotics on pathogen recovery in hematogenous vertebral osteomyelitis,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 52, no. 7, pp. 867–872, Apr. 2011, doi: 10.1093/cid/cir062.
[62] W. Zimmerli, “Clinical practice. Vertebral osteomyelitis,” N. Engl. J. Med., vol. 362, no. 11, pp. 1022–1029, Mar. 2010, doi: 10.1056/NEJMcp0910753.
[63] F. Grados, F. X. Lescure, E. Senneville, R. M. Flipo, J. L. Schmit, and P. Fardellone, “Suggestions for managing pyogenic (non-tuberculous) discitis in adults,” Joint Bone Spine, vol. 74, no. 2, pp. 133–139, Mar. 2007, doi: 10.1016/j.jbspin.2006.11.002.
[64] D. K. H. Yee, D. Samartzis, Y.-W. Wong, K. D. K. Luk, and K. M. C. Cheung, “Infective spondylitis in Southern Chinese: a descriptive and comparative study of ninety-one cases,” Spine, vol. 35, no. 6, pp. 635–641, Mar. 2010, doi: 10.1097/BRS.0b013e3181cff4f6.
[65] R. K. Garg and D. S. Somvanshi, “Spinal tuberculosis: a review,” J. Spinal Cord Med., vol. 34, no. 5, pp. 440–454, 2011, doi: 10.1179/2045772311Y.0000000023.
[66] C. B. Josephson, S. Al-Azri, D. J. Smyth, D. Haase, and B. L. Johnston, “A case of Pott’s disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer,” Can. J. Infect. Dis. Med. Microbiol. J. Can. Mal. Infect. Microbiol. Medicale, vol. 21, no. 1, pp. e75-78, 2010, doi: 10.1155/2010/572410.
[67] M. Loibl et al., “Outcome-related co-factors in 105 cases of vertebral osteomyelitis in a tertiary care hospital,” Infection, vol. 42, no. 3, pp. 503–510, Jun. 2014, doi: 10.1007/s15010-013-0582-0.
[68] J. M. Greig and M. J. Wood, “Staphylococcus lugdunensis vertebral osteomyelitis,” Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis., vol. 9, no. 11, pp. 1139–1141, Nov. 2003, doi: 10.1046/j.1469-0691.2003.00777.x.
[69] L. Cottle and T. Riordan, “Infectious spondylodiscitis,” J. Infect., vol. 56, no. 6, pp. 401–412, Jun. 2008, doi: 10.1016/j.jinf.2008.02.005.
[70] F. A. Broner, D. E. Garland, and J. E. Zigler, “Spinal infections in the immunocompromised host,” Orthop. Clin. North Am., vol. 27, no. 1, pp. 37–46, Jan. 1996.
[71] R. Tyagi, “Spinal infections in children: A review,” J. Orthop., vol. 13, no. 4, pp. 254–258, Dec. 2016, doi: 10.1016/j.jor.2016.06.005.
[72] C. Hopf, A. Meurer, P. Eysel, and J. D. Rompe, “Operative treatment of spondylodiscitis--what is the most effective approach?,” Neurosurg. Rev., vol. 21, no. 4, pp. 217–225, 1998, doi: 10.1007/BF01105775.
[73] C. Schinkel, M. Gottwald, and H.-J. Andress, “Surgical treatment of spondylodiscitis,” Surg. Infect., vol. 4, no. 4, pp. 387–391, 2003, doi: 10.1089/109629603322761445.
[74] C.-Y. Chuo et al., “Spinal infection in intravenous drug abusers,” J. Spinal Disord. Tech., vol. 20, no. 4, pp. 324–328, Jun. 2007, doi: 10.1097/BSD.0b013e31802c144a.
[75] Z. Chen, P. Cao, Z. Zhou, Y. Yuan, Y. Jiao, and Y. Zheng, “Overview: the role of Propionibacterium acnes in nonpyogenic intervertebral discs,” Int. Orthop., vol. 40, no. 6, pp. 1291–1298, Jun. 2016, doi: 10.1007/s00264-016-3115-5.
[76] K. Saeed et al., “Hot topics on vertebral osteomyelitis from the International Society of Antimicrobial Chemotherapy,” Int. J. Antimicrob. Agents, vol. 54, no. 2, pp. 125–133, Aug. 2019, doi: 10.1016/j.ijantimicag.2019.06.013.
[77] E. F. Berbari et al., “2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa,” Clin. Infect. Dis., vol. 61, no. 6, pp. e26–e46, Sep. 2015, doi: 10.1093/cid/civ482.
[78] E. Mylona, M. Samarkos, E. Kakalou, P. Fanourgiakis, and A. Skoutelis, “Pyogenic Vertebral Osteomyelitis: A Systematic Review of Clinical Characteristics,” Semin. Arthritis Rheum., vol. 39, no. 1, pp. 10–17, Aug. 2009, doi: 10.1016/j.semarthrit.2008.03.002.
[79] Z. A. Memish and H. H. Balkhy, “Brucellosis and international travel,” J. Travel Med., vol. 11, no. 1, pp. 49–55, Feb. 2004, doi: 10.2310/7060.2004.13551.
[80] L. I. Sakkas et al., “Hematogenous spinal infection in central Greece,” Spine, vol. 34, no. 15, pp. E513-518, Jul. 2009, doi: 10.1097/BRS.0b013e3181a9897e.
[81] L. D. Herron, P. Kissel, and D. Smilovitz, “Treatment of coccidioidal spinal infection: experience in 16 cases,” J. Spinal Disord., vol. 10, no. 3, pp. 215–222, Jun. 1997.
[82] T. N. Joshi, “Candida albicans spondylodiscitis in an immunocompetent patient,” J. Neurosci. Rural Pract., vol. 3, no. 2, pp. 221–222, May 2012, doi: 10.4103/0976-3147.98261.
[83] A. Gennari, F. Almairac, S. Litrico, C. Albert, P. Marty, and P. Paquis, “Spinal cord compression due to a primary vertebral hydatid disease: A rare case report in metropolitan France and a literature review,” Neurochirurgie., vol. 62, no. 4, pp. 226–228, Aug. 2016, doi: 10.1016/j.neuchi.2016.03.001.
[84] F. Roblot et al., “Optimal duration of antibiotic therapy in vertebral osteomyelitis,” Semin. Arthritis Rheum., vol. 36, no. 5, pp. 269–277, Apr. 2007, doi: 10.1016/j.semarthrit.2006.09.004.
[85] E. Pola et al., “New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years,” Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc., vol. 26, no. Suppl 4, pp. 479–488, 2017, doi: 10.1007/s00586-017-5043-5.
[86] P. Viale et al., “Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin,” Int. J. Antimicrob. Agents, vol. 33, no. 4, pp. 379–382, Apr. 2009, doi: 10.1016/j.ijantimicag.2008.09.011.
[87] C. Liu et al., “Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary,” Clin. Infect. Dis., vol. 52, no. 3, pp. 285–292, Feb. 2011, doi: 10.1093/cid/cir034.
[88] Baddour Larry M. et al., “Infective Endocarditis,” Circulation, vol. 111, no. 23, pp. e394–e434, Jun. 2005, doi: 10.1161/CIRCULATIONAHA.105.165564.
[89] W. Graninger and R. Ragette, “Nosocomial Bacteremia Due to Enterococcus faecalis without Endocarditis,” Clin. Infect. Dis., vol. 15, no. 1, pp. 49–57, Jul. 1992, doi: 10.1093/clinids/15.1.49.
[90] A. D. Tice et al., “Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy,” Clin. Infect. Dis., vol. 38, no. 12, pp. 1651–1671, Jun. 2004, doi: 10.1086/420939.
[91] H. M. Blumberg et al., “American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis,” Am. J. Respir. Crit. Care Med., vol. 167, no. 4, pp. 603–662, Feb. 2003, doi: 10.1164/rccm.167.4.603.
[92] T. Shi et al., “Retrospective Study of 967 Patients With Spinal Tuberculosis,” Orthopedics, vol. 39, no. 5, pp. e838-843, Sep. 2016, doi: 10.3928/01477447-20160509-03.
[93] S. W. Chapman et al., “Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 46, no. 12, pp. 1801–1812, Jun. 2008, doi: 10.1086/588300.
[94] T. J. Walsh et al., “Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 46, no. 3, pp. 327–360, Feb. 2008, doi: 10.1086/525258.
[95] P. J. Carek, L. M. Dickerson, and J. L. Sack, “Diagnosis and management of osteomyelitis,” Am. Fam. Physician, vol. 63, no. 12, pp. 2413–2420, Jun. 2001.
[96] L. Lazzarini, F. De Lalla, and J. T. Mader, “Long Bone Osteomyelitis,” Curr. Infect. Dis. Rep., vol. 4, no. 5, pp. 439–445, Oct. 2002, doi: 10.1007/s11908-002-0012-4.
[97] N. Bettini, M. Girardo, E. Dema, and S. Cervellati, “Evaluation of conservative treatment of non specific spondylodiscitis,” Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc., vol. 18 Suppl 1, pp. 143–150, Jun. 2009, doi: 10.1007/s00586-009-0979-8.
[98] M. Chelli Bouaziz, M. F. Ladeb, M. Chakroun, and S. Chaabane, “Spinal brucellosis: a review,” Skeletal Radiol., vol. 37, no. 9, pp. 785–790, Sep. 2008, doi: 10.1007/s00256-007-0371-x.
[99] C. Liu et al., “Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 52, no. 3, pp. 285–292, Feb. 2011, doi: 10.1093/cid/cir034.
[100] K. Zarghooni, M. Röllinghoff, R. Sobottke, and P. Eysel, “Treatment of spondylodiscitis,” Int. Orthop., vol. 36, no. 2, pp. 405–411, Feb. 2012, doi: 10.1007/s00264-011-1425-1.
[101] H.-K. Li et al., “Oral versus Intravenous Antibiotics for Bone and Joint Infection,” N. Engl. J. Med., vol. 380, no. 5, pp. 425–436, 31 2019, doi: 10.1056/NEJMoa1710926.
[102] P. C. Hsieh, R. J. Wienecke, B. A. O’Shaughnessy, T. R. Koski, and S. L. Ondra, “Surgical strategies for vertebral osteomyelitis and epidural abscess,” Neurosurg. Focus, vol. 17, no. 6, p. E4, Dec. 2004, doi: 10.3171/foc.2004.17.6.4.
[103] W.-H. Chen, L.-S. Jiang, and L.-Y. Dai, “Surgical treatment of pyogenic vertebral osteomyelitis with spinal instrumentation,” Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc., vol. 16, no. 9, pp. 1307–1316, Sep. 2007, doi: 10.1007/s00586-006-0251-4.
[104] L. A. Nasto et al., “Is posterior percutaneous screw-rod instrumentation a safe and effective alternative approach to TLSO rigid bracing for single-level pyogenic spondylodiscitis? Results of a retrospective cohort analysis,” Spine J. Off. J. North Am. Spine Soc., vol. 14, no. 7, pp. 1139–1146, Jul. 2014, doi: 10.1016/j.spinee.2013.07.479.
[105] P. Korovessis, V. Syrimpeis, V. Tsekouras, A. Baikousis, K. Vardakastanis, and P. Fennema, “A unilateral less invasive posterolateral approach for disc debridement and titanium cage insertion supplemented by contralateral transfascial screw fixation for high-morbidity patients suffering from septic thoracolumbosacral spondylodiscitis,” Eur. J. Orthop. Surg. Traumatol. Orthop. Traumatol., vol. 29, no. 6, pp. 1187–1197, Aug. 2019, doi: 10.1007/s00590-019-02434-2.
[106] S. A. Rath, U. Neff, O. Schneider, and H. P. Richter, “Neurosurgical management of thoracic and lumbar vertebral osteomyelitis and discitis in adults: a review of 43 consecutive surgically treated patients,” Neurosurgery, vol. 38, no. 5, pp. 926–933, May 1996, doi: 10.1097/00006123-199605000-00013.
[107] A. F. Mavrogenis et al., “When and how to operate on spondylodiscitis: a report of 13 patients,” Eur. J. Orthop. Surg. Traumatol. Orthop. Traumatol., vol. 26, no. 1, pp. 31–40, Jan. 2016, doi: 10.1007/s00590-015-1674-6.
[108] G. D. Sundararaj, R. Amritanand, K. Venkatesh, and J. Arockiaraj, “The use of titanium mesh cages in the reconstruction of anterior column defects in active spinal infections: can we rest the crest?,” Asian Spine J., vol. 5, no. 3, pp. 155–161, Sep. 2011, doi: 10.4184/asj.2011.5.3.155.
[109] E. J. Karadimas et al., “Spondylodiscitis. A retrospective study of 163 patients,” Acta Orthop., vol. 79, no. 5, pp. 650–659, Oct. 2008, doi: 10.1080/17453670810016678.
[110] M. Di Silvestre, G. Bakaloudis, F. Lolli, and S. Giacomini, “Late-developing infection following posterior fusion for adolescent idiopathic scoliosis,” Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc., vol. 20 Suppl 1, pp. S121-127, May 2011, doi: 10.1007/s00586-011-1754-1.
[2] R. R. Calderone and J. M. Larsen, “Overview and classification of spinal infections,” Orthop. Clin. North Am., vol. 27, no. 1, pp. 1–8, Jan. 1996.
[3] L. Grammatico et al., “Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002–2003,” Epidemiol. Infect., vol. 136, no. 5, pp. 653–660, May 2008, doi: 10.1017/S0950268807008850.
[4] K. Y. Lee, “Comparison of Pyogenic Spondylitis and Tuberculous Spondylitis,” Asian Spine J., vol. 8, no. 2, p. 216, 2014, doi: 10.4184/asj.2014.8.2.216.
[5] A. G. Jensen, F. Espersen, P. Skinhøj, V. T. Rosdahl, and N. Frimodt-Møller, “Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980–1990,” J. Infect., vol. 34, no. 2, pp. 113–118, Mar. 1997, doi: 10.1016/S0163-4453(97)92395-1.
[6] J. Solera, E. Lozano, E. Martinez-Alfaro, A. Espinosa, M. L. Castillejos, and L. Abad, “Brucellar Spondylitis: Review of 35 Cases and Literature Survey,” Clin. Infect. Dis., vol. 29, no. 6, pp. 1440–1449, Dec. 1999, doi: 10.1086/313524.
[7] J. L. Cebrián Parra, A. Saez-Arenillas Martín, A. L. Urda Martínez-Aedo, I. Soler Ivañez, E. Agreda, and L. Lopez-Duran Stern, “Management of infectious discitis. Outcome in one hundred and eight patients in a University Hospital,” Int. Orthop., vol. 36, no. 2, pp. 239–244, Feb. 2012, doi: 10.1007/s00264-011-1445-x.
[8] E. T. Tali, “Spinal infections,” Eur. J. Radiol., vol. 50, no. 2, pp. 120–133, May 2004, doi: 10.1016/j.ejrad.2003.10.022.
[9] A. S. Smith and S. I. Blaser, “Infectious and inflammatory processes of the spine,” Radiol. Clin. North Am., vol. 29, no. 4, pp. 809–827, Jul. 1991.
[10] M. J. Patzakis, S. Rao, J. Wilkins, T. M. Moore, and P. J. Harvey, “Analysis of 61 cases of vertebral osteomyelitis,” Clin. Orthop., no. 264, pp. 178–183, Mar. 1991.
[11] J. D. Colmenero et al., “Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases,” Ann. Rheum. Dis., vol. 56, no. 12, pp. 709–715, Dec. 1997, doi: 10.1136/ard.56.12.709.
[12] J. F. Griffith, S. M. Kumta, P. C. Leung, J. C. Y. Cheng, L. T. C. Chow, and C. Metreweli, “Imaging of musculoskeletal tuberculosis: a new look at an old disease,” Clin. Orthop., no. 398, pp. 32–39, May 2002, doi: 10.1097/00003086-200205000-00006.
[13] D. W. Park et al., “Outcome and management of spinal tuberculosis according to the severity of disease: a retrospective study of 137 adult patients at Korean teaching hospitals,” Spine, vol. 32, no. 4, pp. E130-135, Feb. 2007, doi: 10.1097/01.brs.0000255216.54085.21.
[14] D. L. Larson, K. A. Hudak, W. P. Waring, M. R. Orr, and K. Simonelic, “Protocol management of late-stage pressure ulcers: a 5-year retrospective study of 101 consecutive patients with 179 ulcers,” Plast. Reconstr. Surg., vol. 129, no. 4, pp. 897–904, Apr. 2012, doi: 10.1097/PRS.0b013e3182442197.
[15] M. A. Ameer, T. L. Knorr, and F. B. Mesfin, “Spinal Epidural Abscess,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2020.
[16] C. Michel-Batôt et al., “A particular form of septic arthritis: septic arthritis of facet joint,” Joint Bone Spine, vol. 75, no. 1, pp. 78–83, Jan. 2008, doi: 10.1016/j.jbspin.2007.02.006.
[17] V. Dufour et al., “Comparative study of postoperative and spontaneous pyogenic spondylodiscitis,” Semin. Arthritis Rheum., vol. 34, no. 5, pp. 766–771, Apr. 2005, doi: 10.1016/j.semarthrit.2004.08.004.
[18] M. A. Weinstein and F. J. Eismont, “Infections of the spine in patients with human immunodeficiency virus,” J. Bone Joint Surg. Am., vol. 87, no. 3, pp. 604–609, Mar. 2005, doi: 10.2106/JBJS.C.01062.
[19] A. Di Martino, R. Papalia, E. Albo, L. Diaz, L. Denaro, and V. Denaro, “Infection after spinal surgery and procedures,” Eur. Rev. Med. Pharmacol. Sci., vol. 23, no. 2 Suppl, pp. 173–178, Apr. 2019, doi: 10.26355/eurrev_201904_17487.
[20] N. A. S. Sai Kiran, S. Vaishya, S. S. Kale, B. S. Sharma, and A. K. Mahapatra, “Surgical results in patients with tuberculosis of the spine and severe lower-extremity motor deficits: a retrospective study of 48 patients,” J. Neurosurg. Spine, vol. 6, no. 4, pp. 320–326, Apr. 2007, doi: 10.3171/spi.2007.6.4.6.
[21] A. S. Baker, R. G. Ojemann, M. N. Swartz, and E. P. Richardson, “Spinal epidural abscess,” N. Engl. J. Med., vol. 293, no. 10, pp. 463–468, Sep. 1975, doi: 10.1056/NEJM197509042931001.
[22] A. M. Wiley and J. Trueta, “The vascular anatomy of the spine and its relationship to pyogenic vertebral osteomyelitis,” J. Bone Joint Surg. Br., vol. 41-B, pp. 796–809, Nov. 1959, doi: 10.1302/0301-620X.41B4.796.
[23] E. F. Berbari et al., “2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 61, no. 6, pp. e26-46, Sep. 2015, doi: 10.1093/cid/civ482.
[24] A. Rivas-Garcia, S. Sarria-Estrada, C. Torrents-Odin, L. Casas-Gomila, and E. Franquet, “Imaging findings of Pott’s disease,” Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc., vol. 22 Suppl 4, pp. 567–578, Jun. 2013, doi: 10.1007/s00586-012-2333-9.
[25] M. N. Gamaletsou et al., “Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome,” J. Infect., vol. 68, no. 5, pp. 478–493, May 2014, doi: 10.1016/j.jinf.2013.12.008.
[26] P. Kapeller et al., “Pyogenic infectious spondylitis: clinical, laboratory and MRI features,” Eur. Neurol., vol. 38, no. 2, pp. 94–98, 1997, doi: 10.1159/000113167.
[27] A. F. Mavrogenis, G. K. Triantafyllopoulos, K. Kokkinis, A. Stefos, N. V. Sipsas, and S. G. Pneumaticos, “Continuous L3 spondylitis caused by an infected endovascular aortic graft,” Surg. Infect., vol. 15, no. 6, pp. 861–862, Dec. 2014, doi: 10.1089/sur.2013.219.
[28] O. V. Batson, “The vertebral system of veins as a means for cancer dissemination,” Prog. Clin. Cancer, vol. 3, pp. 1–18, 1967.
[29] W.-C. Chang, H.-K. Tsou, T.-H. Kao, M.-Y. Yang, and C.-C. Shen, “Successful treatment of extended epidural abscess and long segment osteomyelitis: a case report and review of the literature,” Surg. Neurol., vol. 69, no. 2, pp. 117–120; discussion 120, Feb. 2008, doi: 10.1016/j.surneu.2006.12.047.
[30] F. L. Sapico and J. Z. Montgomerie, “Pyogenic vertebral osteomyelitis: report of nine cases and review of the literature,” Rev. Infect. Dis., vol. 1, no. 5, pp. 754–776, Oct. 1979, doi: 10.1093/clinids/1.5.754.
[31] M. Fantoni et al., “Epidemiological and clinical features of pyogenic spondylodiscitis,” Eur. Rev. Med. Pharmacol. Sci., vol. 16 Suppl 2, pp. 2–7, Apr. 2012.
[32] J. S. Butler, M. J. Shelly, M. Timlin, W. G. Powderly, and J. M. O’Byrne, “Nontuberculous pyogenic spinal infection in adults: a 12-year experience from a tertiary referral center,” Spine, vol. 31, no. 23, pp. 2695–2700, Nov. 2006, doi: 10.1097/01.brs.0000244662.78725.37.
[33] C. E. C. Goertz et al., “Brucella sp. vertebral osteomyelitis with intercurrent fatal Staphylococcus aureus toxigenic enteritis in a bottlenose dolphin (Tursiops truncatus),” J. Vet. Diagn. Investig. Off. Publ. Am. Assoc. Vet. Lab. Diagn. Inc, vol. 23, no. 4, pp. 845–851, Jul. 2011, doi: 10.1177/1040638711407683.
[34] A. L. Gasbarrini et al., “Clinical features, diagnostic and therapeutic approaches to haematogenous vertebral osteomyelitis,” Eur. Rev. Med. Pharmacol. Sci., vol. 9, no. 1, pp. 53–66, Feb. 2005.
[35] W. T. Davis, M. D. April, S. Mehta, B. Long, and S. Shroyer, “High risk clinical characteristics for pyogenic spinal infection in acute neck or back pain: Prospective cohort study,” Am. J. Emerg. Med., vol. 38, no. 3, pp. 491–496, 2020, doi: 10.1016/j.ajem.2019.05.025.
[36] W. Y. Cheung and K. D. K. Luk, “Pyogenic spondylitis,” Int. Orthop., vol. 36, no. 2, pp. 397–404, Feb. 2012, doi: 10.1007/s00264-011-1384-6.
[37] A. F. Mavrogenis et al., “Spondylodiscitis revisited,” EFORT Open Rev., vol. 2, no. 11, pp. 447–461, Nov. 2017, doi: 10.1302/2058-5241.2.160062.
[38] T. Aagaard, C. Roed, C. Dragsted, and P. Skinhøj, “Microbiological and therapeutic challenges in infectious spondylodiscitis: a cohort study of 100 cases, 2006-2011,” Scand. J. Infect. Dis., vol. 45, no. 6, pp. 417–424, Jun. 2013, doi: 10.3109/00365548.2012.753160.
[39] S. Choi et al., “Diagnostic usefulness of the QuantiFERON-TB gold in-tube test (QFT-GIT) for tuberculous vertebral osteomyelitis,” Infect. Dis. Lond. Engl., vol. 50, no. 5, pp. 346–351, 2018, doi: 10.1080/23744235.2017.1410282.
[40] E. Mylona, M. Samarkos, E. Kakalou, P. Fanourgiakis, and A. Skoutelis, “Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics,” Semin. Arthritis Rheum., vol. 39, no. 1, pp. 10–17, Aug. 2009, doi: 10.1016/j.semarthrit.2008.03.002.
[41] S. Rajasekaran, “The problem of deformity in spinal tuberculosis,” Clin. Orthop., no. 398, pp. 85–92, May 2002, doi: 10.1097/00003086-200205000-00012.
[42] V. Jevtic, “Vertebral infection,” Eur. Radiol., vol. 14 Suppl 3, pp. E43-52, Mar. 2004, doi: 10.1007/s00330-003-2046-x.
[43] A. Dagirmanjian, J. Schils, and M. C. McHenry, “MR imaging of spinal infections,” Magn. Reson. Imaging Clin. N. Am., vol. 7, no. 3, pp. 525–538, Aug. 1999.
[44] F. Maiuri, G. Iaconetta, B. Gallicchio, A. Manto, and F. Briganti, “Spondylodiscitis. Clinical and magnetic resonance diagnosis,” Spine, vol. 22, no. 15, pp. 1741–1746, Aug. 1997, doi: 10.1097/00007632-199708010-00012.
[45] M. M. Thurnher and R. Bammer, “Diffusion-weighted magnetic resonance imaging of the spine and spinal cord,” Semin. Roentgenol., vol. 41, no. 4, pp. 294–311, Oct. 2006, doi: 10.1053/j.ro.2006.07.003.
[46] E. J. Carragee, “Pyogenic vertebral osteomyelitis,” J. Bone Joint Surg. Am., vol. 79, no. 6, pp. 874–880, Jun. 1997, doi: 10.2106/00004623-199706000-00011.
[47] E. Lazzeri et al., “Clinical feasibility of two-step streptavidin/111In-biotin scintigraphy in patients with suspected vertebral osteomyelitis,” Eur. J. Nucl. Med. Mol. Imaging, vol. 31, no. 11, pp. 1505–1511, Nov. 2004, doi: 10.1007/s00259-004-1581-2.
[48] A. Lupetti, M. M. Welling, U. Mazzi, P. H. Nibbering, and E. K. J. Pauwels, “Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections,” Eur. J. Nucl. Med. Mol. Imaging, vol. 29, no. 5, pp. 674–679, May 2002, doi: 10.1007/s00259-001-0760-7.
[49] A. S. Tamm and J. T. Abele, “Bone and Gallium Single-Photon Emission Computed Tomography-Computed Tomography is Equivalent to Magnetic Resonance Imaging in the Diagnosis of Infectious Spondylodiscitis: A Retrospective Study,” Can. Assoc. Radiol. J. J. Assoc. Can. Radiol., vol. 68, no. 1, pp. 41–46, Feb. 2017, doi: 10.1016/j.carj.2016.02.003.
[50] S. Gratz et al., “18F-FDG hybrid PET in patients with suspected spondylitis,” Eur. J. Nucl. Med. Mol. Imaging, vol. 29, no. 4, pp. 516–524, Apr. 2002, doi: 10.1007/s00259-001-0719-8.
[51] K. Strobel and K. D. M. Stumpe, “PET/CT in musculoskeletal infection,” Semin. Musculoskelet. Radiol., vol. 11, no. 4, pp. 353–364, Dec. 2007, doi: 10.1055/s-2008-1060337.
[52] S. C. Foreman et al., “MR and CT Imaging to Optimize CT-Guided Biopsies in Suspected Spondylodiscitis,” World Neurosurg., vol. 99, pp. 726-734.e7, Mar. 2017, doi: 10.1016/j.wneu.2016.11.017.
[53] F. S. Chew and M. J. Kline, “Diagnostic yield of CT-guided percutaneous aspiration procedures in suspected spontaneous infectious diskitis,” Radiology, vol. 218, no. 1, pp. 211–214, Jan. 2001, doi: 10.1148/radiology.218.1.r01ja06211.
[54] A. Olscamp, J. Rollins, S. S. Tao, and N. A. Ebraheim, “Complications of CT-guided biopsy of the spine and sacrum,” Orthopedics, vol. 20, no. 12, pp. 1149–1152, Dec. 1997.
[55] F. Lecouvet, L. Irenge, B. Vandercam, A. Nzeusseu, S. Hamels, and J.-L. Gala, “The etiologic diagnosis of infectious discitis is improved by amplification-based DNA analysis,” Arthritis Rheum., vol. 50, no. 9, pp. 2985–2994, Sep. 2004, doi: 10.1002/art.20462.
[56] G. Wang et al., “Diagnostic accuracy evaluation of the conventional and molecular tests for Spinal Tuberculosis in a cohort, head-to-head study,” Emerg. Microbes Infect., vol. 7, no. 1, p. 109, Jun. 2018, doi: 10.1038/s41426-018-0114-1.
[57] G. Gras et al., “Microbiological diagnosis of vertebral osteomyelitis: relevance of second percutaneous biopsy following initial negative biopsy and limited yield of post-biopsy blood cultures,” Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol., vol. 33, no. 3, pp. 371–375, Mar. 2014, doi: 10.1007/s10096-013-1965-y.
[58] K. Fuursted, M. Arpi, B. E. Lindblad, and L. N. Pedersen, “Broad-range PCR as a supplement to culture for detection of bacterial pathogens in patients with a clinically diagnosed spinal infection,” Scand. J. Infect. Dis., vol. 40, no. 10, pp. 772–777, 2008, doi: 10.1080/00365540802119994.
[59] A. Navarro-Martínez, E. Navarro, M. J. Castaño, and J. Solera, “Rapid diagnosis of human brucellosis by quantitative real-time PCR: a case report of brucellar spondylitis,” J. Clin. Microbiol., vol. 46, no. 1, pp. 385–387, Jan. 2008, doi: 10.1128/JCM.01303-07.
[60] E. M. de Lucas et al., “CT-guided fine-needle aspiration in vertebral osteomyelitis: true usefulness of a common practice,” Clin. Rheumatol., vol. 28, no. 3, pp. 315–320, Mar. 2009, doi: 10.1007/s10067-008-1051-5.
[61] J. Marschall, K. P. Bhavan, M. A. Olsen, V. J. Fraser, N. M. Wright, and D. K. Warren, “The impact of prebiopsy antibiotics on pathogen recovery in hematogenous vertebral osteomyelitis,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 52, no. 7, pp. 867–872, Apr. 2011, doi: 10.1093/cid/cir062.
[62] W. Zimmerli, “Clinical practice. Vertebral osteomyelitis,” N. Engl. J. Med., vol. 362, no. 11, pp. 1022–1029, Mar. 2010, doi: 10.1056/NEJMcp0910753.
[63] F. Grados, F. X. Lescure, E. Senneville, R. M. Flipo, J. L. Schmit, and P. Fardellone, “Suggestions for managing pyogenic (non-tuberculous) discitis in adults,” Joint Bone Spine, vol. 74, no. 2, pp. 133–139, Mar. 2007, doi: 10.1016/j.jbspin.2006.11.002.
[64] D. K. H. Yee, D. Samartzis, Y.-W. Wong, K. D. K. Luk, and K. M. C. Cheung, “Infective spondylitis in Southern Chinese: a descriptive and comparative study of ninety-one cases,” Spine, vol. 35, no. 6, pp. 635–641, Mar. 2010, doi: 10.1097/BRS.0b013e3181cff4f6.
[65] R. K. Garg and D. S. Somvanshi, “Spinal tuberculosis: a review,” J. Spinal Cord Med., vol. 34, no. 5, pp. 440–454, 2011, doi: 10.1179/2045772311Y.0000000023.
[66] C. B. Josephson, S. Al-Azri, D. J. Smyth, D. Haase, and B. L. Johnston, “A case of Pott’s disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer,” Can. J. Infect. Dis. Med. Microbiol. J. Can. Mal. Infect. Microbiol. Medicale, vol. 21, no. 1, pp. e75-78, 2010, doi: 10.1155/2010/572410.
[67] M. Loibl et al., “Outcome-related co-factors in 105 cases of vertebral osteomyelitis in a tertiary care hospital,” Infection, vol. 42, no. 3, pp. 503–510, Jun. 2014, doi: 10.1007/s15010-013-0582-0.
[68] J. M. Greig and M. J. Wood, “Staphylococcus lugdunensis vertebral osteomyelitis,” Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis., vol. 9, no. 11, pp. 1139–1141, Nov. 2003, doi: 10.1046/j.1469-0691.2003.00777.x.
[69] L. Cottle and T. Riordan, “Infectious spondylodiscitis,” J. Infect., vol. 56, no. 6, pp. 401–412, Jun. 2008, doi: 10.1016/j.jinf.2008.02.005.
[70] F. A. Broner, D. E. Garland, and J. E. Zigler, “Spinal infections in the immunocompromised host,” Orthop. Clin. North Am., vol. 27, no. 1, pp. 37–46, Jan. 1996.
[71] R. Tyagi, “Spinal infections in children: A review,” J. Orthop., vol. 13, no. 4, pp. 254–258, Dec. 2016, doi: 10.1016/j.jor.2016.06.005.
[72] C. Hopf, A. Meurer, P. Eysel, and J. D. Rompe, “Operative treatment of spondylodiscitis--what is the most effective approach?,” Neurosurg. Rev., vol. 21, no. 4, pp. 217–225, 1998, doi: 10.1007/BF01105775.
[73] C. Schinkel, M. Gottwald, and H.-J. Andress, “Surgical treatment of spondylodiscitis,” Surg. Infect., vol. 4, no. 4, pp. 387–391, 2003, doi: 10.1089/109629603322761445.
[74] C.-Y. Chuo et al., “Spinal infection in intravenous drug abusers,” J. Spinal Disord. Tech., vol. 20, no. 4, pp. 324–328, Jun. 2007, doi: 10.1097/BSD.0b013e31802c144a.
[75] Z. Chen, P. Cao, Z. Zhou, Y. Yuan, Y. Jiao, and Y. Zheng, “Overview: the role of Propionibacterium acnes in nonpyogenic intervertebral discs,” Int. Orthop., vol. 40, no. 6, pp. 1291–1298, Jun. 2016, doi: 10.1007/s00264-016-3115-5.
[76] K. Saeed et al., “Hot topics on vertebral osteomyelitis from the International Society of Antimicrobial Chemotherapy,” Int. J. Antimicrob. Agents, vol. 54, no. 2, pp. 125–133, Aug. 2019, doi: 10.1016/j.ijantimicag.2019.06.013.
[77] E. F. Berbari et al., “2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa,” Clin. Infect. Dis., vol. 61, no. 6, pp. e26–e46, Sep. 2015, doi: 10.1093/cid/civ482.
[78] E. Mylona, M. Samarkos, E. Kakalou, P. Fanourgiakis, and A. Skoutelis, “Pyogenic Vertebral Osteomyelitis: A Systematic Review of Clinical Characteristics,” Semin. Arthritis Rheum., vol. 39, no. 1, pp. 10–17, Aug. 2009, doi: 10.1016/j.semarthrit.2008.03.002.
[79] Z. A. Memish and H. H. Balkhy, “Brucellosis and international travel,” J. Travel Med., vol. 11, no. 1, pp. 49–55, Feb. 2004, doi: 10.2310/7060.2004.13551.
[80] L. I. Sakkas et al., “Hematogenous spinal infection in central Greece,” Spine, vol. 34, no. 15, pp. E513-518, Jul. 2009, doi: 10.1097/BRS.0b013e3181a9897e.
[81] L. D. Herron, P. Kissel, and D. Smilovitz, “Treatment of coccidioidal spinal infection: experience in 16 cases,” J. Spinal Disord., vol. 10, no. 3, pp. 215–222, Jun. 1997.
[82] T. N. Joshi, “Candida albicans spondylodiscitis in an immunocompetent patient,” J. Neurosci. Rural Pract., vol. 3, no. 2, pp. 221–222, May 2012, doi: 10.4103/0976-3147.98261.
[83] A. Gennari, F. Almairac, S. Litrico, C. Albert, P. Marty, and P. Paquis, “Spinal cord compression due to a primary vertebral hydatid disease: A rare case report in metropolitan France and a literature review,” Neurochirurgie., vol. 62, no. 4, pp. 226–228, Aug. 2016, doi: 10.1016/j.neuchi.2016.03.001.
[84] F. Roblot et al., “Optimal duration of antibiotic therapy in vertebral osteomyelitis,” Semin. Arthritis Rheum., vol. 36, no. 5, pp. 269–277, Apr. 2007, doi: 10.1016/j.semarthrit.2006.09.004.
[85] E. Pola et al., “New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years,” Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc., vol. 26, no. Suppl 4, pp. 479–488, 2017, doi: 10.1007/s00586-017-5043-5.
[86] P. Viale et al., “Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin,” Int. J. Antimicrob. Agents, vol. 33, no. 4, pp. 379–382, Apr. 2009, doi: 10.1016/j.ijantimicag.2008.09.011.
[87] C. Liu et al., “Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary,” Clin. Infect. Dis., vol. 52, no. 3, pp. 285–292, Feb. 2011, doi: 10.1093/cid/cir034.
[88] Baddour Larry M. et al., “Infective Endocarditis,” Circulation, vol. 111, no. 23, pp. e394–e434, Jun. 2005, doi: 10.1161/CIRCULATIONAHA.105.165564.
[89] W. Graninger and R. Ragette, “Nosocomial Bacteremia Due to Enterococcus faecalis without Endocarditis,” Clin. Infect. Dis., vol. 15, no. 1, pp. 49–57, Jul. 1992, doi: 10.1093/clinids/15.1.49.
[90] A. D. Tice et al., “Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy,” Clin. Infect. Dis., vol. 38, no. 12, pp. 1651–1671, Jun. 2004, doi: 10.1086/420939.
[91] H. M. Blumberg et al., “American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis,” Am. J. Respir. Crit. Care Med., vol. 167, no. 4, pp. 603–662, Feb. 2003, doi: 10.1164/rccm.167.4.603.
[92] T. Shi et al., “Retrospective Study of 967 Patients With Spinal Tuberculosis,” Orthopedics, vol. 39, no. 5, pp. e838-843, Sep. 2016, doi: 10.3928/01477447-20160509-03.
[93] S. W. Chapman et al., “Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 46, no. 12, pp. 1801–1812, Jun. 2008, doi: 10.1086/588300.
[94] T. J. Walsh et al., “Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 46, no. 3, pp. 327–360, Feb. 2008, doi: 10.1086/525258.
[95] P. J. Carek, L. M. Dickerson, and J. L. Sack, “Diagnosis and management of osteomyelitis,” Am. Fam. Physician, vol. 63, no. 12, pp. 2413–2420, Jun. 2001.
[96] L. Lazzarini, F. De Lalla, and J. T. Mader, “Long Bone Osteomyelitis,” Curr. Infect. Dis. Rep., vol. 4, no. 5, pp. 439–445, Oct. 2002, doi: 10.1007/s11908-002-0012-4.
[97] N. Bettini, M. Girardo, E. Dema, and S. Cervellati, “Evaluation of conservative treatment of non specific spondylodiscitis,” Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc., vol. 18 Suppl 1, pp. 143–150, Jun. 2009, doi: 10.1007/s00586-009-0979-8.
[98] M. Chelli Bouaziz, M. F. Ladeb, M. Chakroun, and S. Chaabane, “Spinal brucellosis: a review,” Skeletal Radiol., vol. 37, no. 9, pp. 785–790, Sep. 2008, doi: 10.1007/s00256-007-0371-x.
[99] C. Liu et al., “Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary,” Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., vol. 52, no. 3, pp. 285–292, Feb. 2011, doi: 10.1093/cid/cir034.
[100] K. Zarghooni, M. Röllinghoff, R. Sobottke, and P. Eysel, “Treatment of spondylodiscitis,” Int. Orthop., vol. 36, no. 2, pp. 405–411, Feb. 2012, doi: 10.1007/s00264-011-1425-1.
[101] H.-K. Li et al., “Oral versus Intravenous Antibiotics for Bone and Joint Infection,” N. Engl. J. Med., vol. 380, no. 5, pp. 425–436, 31 2019, doi: 10.1056/NEJMoa1710926.
[102] P. C. Hsieh, R. J. Wienecke, B. A. O’Shaughnessy, T. R. Koski, and S. L. Ondra, “Surgical strategies for vertebral osteomyelitis and epidural abscess,” Neurosurg. Focus, vol. 17, no. 6, p. E4, Dec. 2004, doi: 10.3171/foc.2004.17.6.4.
[103] W.-H. Chen, L.-S. Jiang, and L.-Y. Dai, “Surgical treatment of pyogenic vertebral osteomyelitis with spinal instrumentation,” Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc., vol. 16, no. 9, pp. 1307–1316, Sep. 2007, doi: 10.1007/s00586-006-0251-4.
[104] L. A. Nasto et al., “Is posterior percutaneous screw-rod instrumentation a safe and effective alternative approach to TLSO rigid bracing for single-level pyogenic spondylodiscitis? Results of a retrospective cohort analysis,” Spine J. Off. J. North Am. Spine Soc., vol. 14, no. 7, pp. 1139–1146, Jul. 2014, doi: 10.1016/j.spinee.2013.07.479.
[105] P. Korovessis, V. Syrimpeis, V. Tsekouras, A. Baikousis, K. Vardakastanis, and P. Fennema, “A unilateral less invasive posterolateral approach for disc debridement and titanium cage insertion supplemented by contralateral transfascial screw fixation for high-morbidity patients suffering from septic thoracolumbosacral spondylodiscitis,” Eur. J. Orthop. Surg. Traumatol. Orthop. Traumatol., vol. 29, no. 6, pp. 1187–1197, Aug. 2019, doi: 10.1007/s00590-019-02434-2.
[106] S. A. Rath, U. Neff, O. Schneider, and H. P. Richter, “Neurosurgical management of thoracic and lumbar vertebral osteomyelitis and discitis in adults: a review of 43 consecutive surgically treated patients,” Neurosurgery, vol. 38, no. 5, pp. 926–933, May 1996, doi: 10.1097/00006123-199605000-00013.
[107] A. F. Mavrogenis et al., “When and how to operate on spondylodiscitis: a report of 13 patients,” Eur. J. Orthop. Surg. Traumatol. Orthop. Traumatol., vol. 26, no. 1, pp. 31–40, Jan. 2016, doi: 10.1007/s00590-015-1674-6.
[108] G. D. Sundararaj, R. Amritanand, K. Venkatesh, and J. Arockiaraj, “The use of titanium mesh cages in the reconstruction of anterior column defects in active spinal infections: can we rest the crest?,” Asian Spine J., vol. 5, no. 3, pp. 155–161, Sep. 2011, doi: 10.4184/asj.2011.5.3.155.
[109] E. J. Karadimas et al., “Spondylodiscitis. A retrospective study of 163 patients,” Acta Orthop., vol. 79, no. 5, pp. 650–659, Oct. 2008, doi: 10.1080/17453670810016678.
[110] M. Di Silvestre, G. Bakaloudis, F. Lolli, and S. Giacomini, “Late-developing infection following posterior fusion for adolescent idiopathic scoliosis,” Eur. Spine J. Off. Publ. Eur. Spine Soc. Eur. Spinal Deform. Soc. Eur. Sect. Cerv. Spine Res. Soc., vol. 20 Suppl 1, pp. S121-127, May 2011, doi: 10.1007/s00586-011-1754-1.
Published
2021-04-26
Section
Review
Copyright (c) 2021 Acta Orthopaedica Et Traumatologica Hellenica
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
